Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

Cancers·2026

Same author

Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma.

Journal of clinical medicine·2026

Same author

Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and Agonists.

The Prostate·2026

Same author

Less Can Be Enough: Optimizing Abiraterone Acetate Dosing With Food to Improve Access and Maintain Efficacy in Metastatic Castration-Resistant Prostate Cancer.

JCO global oncology·2026

Same author

CEA and CA-19-9 Dynamics Associate with Survival in Regorafenib-Treated Metastatic Colorectal Cancer: A Real-World Analysis.

Journal of clinical medicine·2026

Same author

Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

JCO global oncology·2026

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Accuracy and usability of artificial intelligence chatbot generated chemotherapy protocols.

Efe Cem Erdat¹, Merih Yalciner¹, Yuksel Urun¹

¹Ankara University Department of Medical Oncology, Ankara, Turkey.

Future Oncology (London, England)

|April 22, 2024

Summary

Artificial intelligence (AI) chatbots show limited accuracy in generating chemotherapy protocols. While AI offers potential, current performance is low, requiring careful use in oncology.

Keywords:

AI chatbots accuracy chemotherapy protocols simulated patients usability

More Related Videos

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

Assessing Specificity of Anticancer Drugs In Vitro

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Related Experiment Videos

Last Updated: Jun 28, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

Assessing Specificity of Anticancer Drugs In Vitro

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Area of Science:

Oncology
Medical Informatics
Artificial Intelligence

Background:

Medical practitioners increasingly use AI chatbots for rapid information retrieval.
The accuracy and availability of AI-generated chemotherapy protocols remain unstudied.
This research addresses a critical gap in understanding AI's role in cancer treatment planning.

Purpose of the Study:

To evaluate the accuracy and availability of chemotherapy protocols generated by AI chatbots.
To compare the performance of different AI models in generating oncological treatment plans.
To assess the potential and limitations of AI chatbots in clinical oncology.

Main Methods:

Nine simulated cancer patient cases were developed.
AI chatbots, ChatGPT (version 3.5) and Bing, generated chemotherapy protocols for each case.
Generated protocols were compared against established treatment plans.

Main Results:

ChatGPT achieved a 5/9 accuracy rate, while Bing achieved a 4/9 accuracy rate.
The difference in performance between the two AI chatbots was not statistically significant (p=1).
Both AI chatbots demonstrated both capabilities and shortcomings in protocol generation.

Conclusions:

AI chatbots have potential but significant limitations in generating chemotherapy protocols.
Current AI performance is insufficient for routine use in oncological practice.
Careful consideration and validation are essential when employing AI chatbots for chemotherapy planning.